Join us at CPHI Frankfurt 2025
28-30 October 2025, Messe Frankfurt, Germany
Booth 9.0B67
At GEA, we work closely with our customers to optimize every step of the process—ensuring quality, improving performance, and delivering #SimplyBetter outcomes.
Offering unparalleled networking opportunities and access to the global pharmaceutical supply chain, CPHI Worldwide provides the perfect platform to connect with industry leaders, expand your network and grow your business. GEA’s dedicated team of experts will be on-site and ready to present the very latest developments in pharmaceutical manufacturing.
Join us on booth 9.0B67 to discover our #SimplyBetter technologies.
With a strong focus on digitalization, sustainability and engineering for future generations, our experts will be available to discuss our latest developments at this year’s event.
Sustainability: By using more renewable power, boosting its energy efficiency and reducing emissions, GEA is prioritizing its environmental roadmap and further developing sustainable solutions that drive the global pharmaceutical industry towards a circular economy.
Digitalization: Embracing ecommerce platforms, virtual reality, Digital Hubs and the GEA Cloud®, GEA is taking a customer-centric approach to increased productivity, better machine availability and successful scaling with the smallest ecological footprint.
Modularization: Aiming to provide operational benefits such as flexibility, scalability and cost-effectiveness, GEA has taken a multifunctionality approach to both its single units to fully integrated lines, such as the NexGen Press® range and the ConsiGma® portfolio.
Containment: The BUCK® Digital Canary monitoring system has revolutionized this field by effectively identifying any breaches in contained pharmaceutical production lines and ensuring the safety of personnel and the products being manufactured.
In addition, the innovative BUCK® AC Valve boasts solvent-resistant functionality to provide enhanced performance and reliability during powder transfer applications such as API production.
Compression: We are also excited to announce that the high-throughput NexGen Press® 45 has also received the Add Better label* (validated by TÜV Rheinland). Following a series of trials, TÜV representatives certified that, in terms of electric power usage, operational utility savings of up to 27% could be made.
* The Add Better label relates to the serial product GEA NexGen Press® 45, released in June 2024.
Continuous: In an industry-first collaboration, Hovione and GEA have partnered to revolutionize drug production. By providing enhanced capacity, combined expertise, standardized equipment, improved quality and increased efficiency, a new paradigm has been set for continuous pharmaceutical tableting. At this CPHI, you can find out more about the new, flexible continuous tableting platform developed in this partnership, ConsiGma® CDC Flex, as well as a range of development tools designed to address key challenges in process development by enhancing efficiency, containment, and operator safety, called SimpleCT.
Homogenization: High-pressure homogenization is a key technology in modern pharmaceutical development, enabling precise particle size reduction, enhanced solubility, and improved bioavailability of active pharmaceutical ingredients (APIs). Its ability to create stable nanoemulsions and nanosuspensions supports the formulation of complex drug delivery systems, including poorly water-soluble compounds.
Beyond formulation, homogenization is also widely applied in cell disruption processes, ensuring efficient release of intracellular products such as proteins, enzymes, and nucleic acids with high reproducibility. This makes it an essential tool in the production of biologics, vaccines, and gene therapy vectors, where consistency and scalability are critical.
By combining efficiency, reliability, and scalability, high-pressure homogenization delivers robust solutions that meet the stringent demands of pharmaceutical innovation.
Lyophilization: Experts in every aspect of pharmaceutical freeze drying, GEA supplies a comprehensive portfolio of high-performance machinery (the LYOVAC® range and ALUS® automatic loading & unloading systems), analytical equipment (LYOPLUS) and solutions that make the entire process more sustainable, such as LYOAIR® and LYOVAC® ECO Mode. Visit our stand to discover the latest development, including LYONOVA® - Microwave-assisted freeze drying to accelerate freeze drying without compromising quality. A breakthrough solution for labs and niche commercial manufacturing.
Spray Drying: Don’t miss the opportunity to explore unprecedented opportunities with GEA ASEPTIC-SD®, advancing sterile powder formulation in pharmaceuticals. Leveraging on decades of experience and state-of-the-art technology, our aseptic spray dryers provide safe and reliable solutions for challenging pharmaceutical applications. Meet with our spray drying experts at the booth to learn more.
Service: Offering a lifetime of operational excellence, equipment maintenance contracts from GEA ensure that your plant delivers the efficiency, productivity and output you need for now and the future. It’s more than machinery, our focus is your peace of mind and eliminating downtime.
With solutions for both solid and liquid applications, batch and continuous processes, and a portfolio of single units, modular systems and complete production lines, we can help you to get your product to market faster with efficient, reliable and planet-friendly solutions. We look forward to meeting you at the event (booth 9.0B67) to highlight the developments and technological breakthroughs that will help to transform tomorrow.
